Colorectal carcinoma antigens detected by hybridoma antibodies.
about
P1343
The epithelial cell adhesion molecule EpCAM is required for epithelial morphogenesis and integrity during zebrafish epiboly and skin developmentSFA-1, a novel cellular gene induced by human T-cell leukemia virus type 1, is a member of the transmembrane 4 superfamilyA Paratransgenic Strategy for the Control of Chagas DiseaseMolecular cloning of cDNA for the human tumor-associated antigen CO-029 and identification of related transmembrane antigensStrategies for early detection of resectable pancreatic cancerIdentification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motilityCA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEAProduction of monoclonal antibodies in plants for cancer immunotherapyPerspectives in the treatment of pancreatic adenocarcinomaThe clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updatesAntibodies: At The Nexus of Antigens and Cancer VaccinesBiomarkers in pancreatic adenocarcinoma: current perspectivesExpression of tumor rejection antigens in colorectal carcinomasInfluence of Lewis alpha1-3/4-L-fucosyltransferase (FUT3) gene mutations on enzyme activity, erythrocyte phenotyping, and circulating tumor marker sialyl-Lewis a levelsThe tumor-associated EpCAM regulates morphogenetic movements through intracellular signaling.Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificityImmunization with recombinantly expressed glycan antigens from Schistosoma mansoni induces glycan-specific antibodies against the parasite.Synthesis of sialyl Lewis(a) (sLe (a), CA19-9) and construction of an immunogenic sLe(a) vaccineSingle-chain antibodies in pancreatic cancer.α3/4 Fucosyltransferase 3-dependent synthesis of Sialyl Lewis A on CD44 variant containing exon 6 mediates polymorphonuclear leukocyte detachment from intestinal epithelium during transepithelial migration.A varying-coefficient cox model for the effect of CA19-9 kinetics on overall survival in patients with advanced pancreatic cancerIdentification of prognostic factors and surgical indications for metastatic gastric cancer.Inhibition of tumor growth by plant-derived mAb.Remembrances of Hilary Koprowski from a Surgeon's Perspective.Intensity of follow-up after pancreatic cancer resectionOverexpression of the epithelial cell adhesion molecule is associated with a more favorable prognosis and response to platinum-based chemotherapy in ovarian cancerExpression of recombinant multi-coloured fluorescent antibodies in gor -/trxB- E. coli cytoplasm.Antitumour reactions of monoclonal antibody against a human osteogenic-sarcoma cell line.AB0 blood group and prognosis in patients with pancreatic cancer.Anti-idiotype immunization of cancer patients: modulation of the immune responseExpression of sialyl Lewis(a) relates to poor prognosis in cholangiocarcinoma.Biology of pancreatic cancerInhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.Module based antibody engineering: a novel synthetic REDantibody.Decreased serum CA19-9 is associated with improvement of insulin resistance and metabolic control in patients with obesity and type 2 diabetes after Roux-en-Y gastric bypass.Comparative effectiveness of the tumour diagnostics, CA 19-9, CA 125 and carcinoembryonic antigen in patients with diseases of the digestive system.Antigenic characterization of human hepatocellular carcinoma. Development of in vitro and in vivo immunoassays that use monoclonal antibodies.Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEADetection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma.Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma.
P2860
Q21563339-76B12F1F-6562-4B54-8D75-E9047459FA5DQ24310639-A8CD5BB0-8A6F-49B1-90FD-CC2CC608064EQ24549209-F79ED83C-29F7-411E-A8F5-58777DDB18E2Q24557431-AEBE65A7-4116-4A84-84A2-0E96177A6012Q24564006-A99E4BC5-84B1-4B59-97B2-FEE62E38101CQ24675573-EEE0F3CE-03B9-4017-837E-ED4A7F93F0A3Q24678824-75AC4643-5792-4F56-BB81-C6FB5D68354DQ26778423-4FEFE0DD-C87F-499E-B0DE-FA31A5B91B53Q26797248-C9629A10-0B4B-40BE-A625-1C7C07755AE7Q26865015-9A3EC4E9-F065-425A-A300-37FFCD8B9542Q27001058-C74019A2-7AA1-423F-A6CD-189BEAE5668BQ28072309-AF90040F-5A6B-46BF-97CF-7A279CC4C6BCQ28211063-29E1D0A0-21D9-4ADB-9625-E2B4BF185885Q28298349-364AF852-DE5A-41C6-8092-6FCAEC41FEE0Q30432515-E25D764F-2E20-4D85-BD3B-59F62909448AQ33586088-CFF01D9C-37D9-441D-8FF5-071C93DA880CQ33684607-42A371A7-B9F9-49F6-8500-3457996D543BQ33689062-A5DAC9F5-9B95-49E2-A0B5-B2C9BBF621EAQ33693014-DD182CEA-6AC3-48D5-AD42-456E7D6A8429Q33720541-08DF19EB-3657-4D50-898C-B138D61B192AQ33728198-8C5BC9DF-C668-46FB-8677-5D69B935AB2CQ33755032-22F6802C-29BB-4C20-A25E-6BB434C8DE4AQ33784553-1F76A524-ECBB-4271-938E-DFC65168079BQ33788898-EE7A4991-02FC-4C8B-8059-2567ED17D65BQ33791048-3DF9D48F-C3C2-4FDB-8C54-633FF4646EF7Q33917340-4E5FD03E-7F43-4C70-84FB-8508F5F851D1Q34086845-F1F8C0A6-5337-4CBC-B8AC-9EC551E29FA0Q34273674-166D709C-FA49-4281-942F-B7D140D52AA6Q34354138-E2050124-A5C2-49F5-ACEF-A67435CB67FEQ34366216-33DB2913-A076-4E25-9B3E-0C044D9E6089Q34382675-44695AFC-DD36-4382-B976-C8FB3B2ABA0EQ34394264-2219B2DB-8A67-4B15-B57F-C1D6F492A471Q34394487-9B7A2A8E-57F2-44E4-A8B0-34B3FF0636C4Q34482418-0B7A8D32-1E8F-443C-B37B-86DCAC71E64FQ34523725-920D3392-B925-40F8-BC21-05F85B25D807Q34526803-C7E16D39-D4C2-4D80-8B5D-4D31457F88E0Q34540356-718E81F3-778F-4991-92EC-189660779D15Q34544953-0510A652-2AF4-4316-830A-ABC042DE2F60Q34548390-284128E9-F299-4CD3-81BA-342F6115D77EQ34568471-623CF3DE-1B06-4C19-A2DE-11DCE4F37B5A
P2860
Colorectal carcinoma antigens detected by hybridoma antibodies.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Colorectal carcinoma antigens detected by hybridoma antibodies.
@en
Colorectal carcinoma antigens detected by hybridoma antibodies.
@nl
type
label
Colorectal carcinoma antigens detected by hybridoma antibodies.
@en
Colorectal carcinoma antigens detected by hybridoma antibodies.
@nl
prefLabel
Colorectal carcinoma antigens detected by hybridoma antibodies.
@en
Colorectal carcinoma antigens detected by hybridoma antibodies.
@nl
P2093
P356
P1476
Colorectal carcinoma antigens detected by hybridoma antibodies.
@en
P2093
P304
P356
10.1007/BF01542654
P4510
P577
1979-11-01T00:00:00Z